Spesolimab

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 232 publications

Resolution of life- and limb-threatening pyoderma gangrenosum with spesolimab.

Resolution of life- and limb-threatening pyoderma gangrenosum with spesolimab.

Journal: JAAD case reports

Published: July 13, 2026

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Journal: Acta dermato-venereologica

Published: June 19, 2026

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Journal: Journal of clinical medicine

Published: June 18, 2026

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Journal: JAAD case reports

Published: May 25, 2026

IL-36-Driven Inflammation in Generalized Pustular Psoriasis: Immunological Insights from Plaque Psoriasis and Implications for Targeted Therapy.

IL-36-Driven Inflammation in Generalized Pustular Psoriasis: Immunological Insights from Plaque Psoriasis and Implications for Targeted Therapy.

Journal: International journal of molecular sciences

Published: April 17, 2026

The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant.

The Role of Genetic Testing in the Differential Diagnosis of Pustular Dermatoses: A Pediatric Case of Generalized Pustular Psoriasis Associated with the IL36RN Variant.

Journal: Journal of clinical medicine

Published: April 08, 2026

Genotype-Phenotype Correlations and Clinical Outcomes of Spesolimab in Acrodermatitis Continua of Hallopeau: A Multicenter Retrospective Cohort Study.

Genotype-Phenotype Correlations and Clinical Outcomes of Spesolimab in Acrodermatitis Continua of Hallopeau: A Multicenter Retrospective Cohort Study.

Journal: Psoriasis (Auckland, N.Z.)

Published: April 01, 2026

Successful use of spesolimab in refractory pyoderma gangrenosum.

Successful use of spesolimab in refractory pyoderma gangrenosum.

Journal: JAAD case reports

Published: March 20, 2026

Unusual Presentation of Pustular Psoriasis on the Face: A Case Report.

Unusual Presentation of Pustular Psoriasis on the Face: A Case Report.

Journal: Cureus

Published: March 12, 2026

Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis.

Effectiveness and Safety of Spesolimab in Adolescents and Adults with Generalized Pustular Psoriasis.

Journal: Pragmatic and observational research

Published: March 12, 2026

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

Journal: JAAD case reports

Published: March 02, 2026

Monotherapy with Biologics for Generalized Pustular Psoriasis: A Systematic Review of Comparative Interventional Studies with an Exploratory Network Meta-Analysis.

Monotherapy with Biologics for Generalized Pustular Psoriasis: A Systematic Review of Comparative Interventional Studies with an Exploratory Network Meta-Analysis.

Journal: Medical sciences (Basel, Switzerland)

Published: February 26, 2026

Showing 1-12 of 232

Last Updated: 09/26/2026